Quantification of human amniotic fluid constituents by high resolution proton nuclear magnetic resonance (NMR) spectroscopy.
We have investigated the ability of high-resolution proton NMR spectroscopy to provide a biochemical constituent screening of human amniotic fluid (AF). Proton NMR spectra were obtained at 300 MHz on AF from patients undergoing amniocentesis in the mid-trimester. Only AF from normal pregnancies (normal fetal karyotype, normal alpha-fetoprotein levels, normal birth outcome) was used in this study. The AF supernatant was lyophilized and resuspended in deuterated water containing 0.1 mM phosphate buffer and 6.02 mM disodium maleate. Identification of low molecular weight compounds was confirmed by two-dimensional NMR spectra (primarily correlated spectroscopy, or COSY) and standard addition techniques. A broad profile of compounds were 'NMR visible' in a single proton spectrum, including creatinine, glucose, organic acids (acetate, citrate, and lactate) and several amino acids (alanine, histidine, leucine, phenylalanine, tyrosine and valine). The proton spectrum was unaffected by prior freezing/thawing of AF samples. We were able to quantify compounds by comparison with an added concentration standard (maleate) at concentrations as low as 30 microM. Good agreement with literature values based on other analytical techniques was obtained.
Department of Obstetrics and Gynecology, Medical College of Pennsylvania/Allegheny Campus, Pittsburgh 15212-9986.
C J
CJ
Sims
D T
DT
Fujito
D R
DR
Burholt
J
J
Dadok
H R
HR
Giles
D A
DA
Wilkinson
D000653:Amniotic Fluid / Q000737:chemistry*; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008970:Molecular Weight; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011522:Protons; D015203:Reproducibility of Results
D011522:Protons